Last reviewed · How we verify
NCT04670562
Longitudinal Follow up of Patients With Pleural Effusion
trial in Pleural Effusion, Malignant in 500 participants. Status unknown.
1 December 2024
Quick facts
| Lead sponsor | Seoul National University Bundang Hospital |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 500 |
| Start date | 1 March 2021 |
| Primary completion | 1 December 2024 |
| Estimated completion | 31 December 2025 |
| Sites | 1 location across South Korea |
Conditions studied
- Pleural Effusion, Malignant — all drugs for Pleural Effusion, Malignant →
- Prognosis — all drugs for Prognosis →
Sponsor
Seoul National University Bundang Hospital
Who can join
Eligibility, any sex, with Pleural Effusion, Malignant or Prognosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to evaluate the clinical course of patients diagnosed with pleural effusion and determine various clinical factors and biomarkers associated that can predict the diagnosis and clinical outcome and prognosis of patients with pleural effusion due to specific causes.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04670562
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pleural Effusion, Malignant
Currently open trials in the same condition.
- NCT06946498 — First Local Anaesthesia Thoracoscopy for Pleural Effusion Diagnosis. · NA · recruiting
- NCT06512896 — Clinical Study on Intraluminal Injection of FOLactis · NA · recruiting
- NCT05268172 — IFN-γ Combined With T Cells in the Treatment of Refractory Malignant Pleural Effusion and Ascites · Phase 1 · recruiting
- NCT04844827 — Pleural Carcinomatosis Tissue Banking · recruiting
- NCT04684459 — Dual-targeting HER2 and PD-L1 CAR-T for Solid Tumors · EARLY_PHASE1 · recruiting
Other Seoul National University Bundang Hospital trials
Trials by the same sponsor.
- NCT07459725 — Comparison of EEG-Timed vs. Repetitive Robot Therapy for Chronic Stroke · NA · not yet recruiting
- NCT07455279 — Surface Electromyographic Analysis of Normal Swallowing in Children: An Exploratory Study · not yet recruiting
- NCT07477574 — Muscle-Specific Multimodal AI for Sarcopenia Diagnosis · NA · not yet recruiting
- NCT07505290 — Efficacy of the Korean PEERS® for Preschoolers (PEERS®-PS-K) Social Skills Intervention: A Randomized Controlled Trial f · NA · active not recruiting
- NCT07305662 — Exploring the Effects of Korean-Style Mediterranean Diet (KORMED) and Physical Activity Measurement in Patients With MGU · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04670562 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Seoul National University Bundang Hospital
- Last refreshed: 22 June 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04670562.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing